help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2008-0466
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Rivas, M.
Right arrow Articles by Naranjo, J. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivas, M.
Right arrow Articles by Naranjo, J. R.
Molecular Endocrinology 23 (6): 862-870
Copyright © 2009 by The Endocrine Society

The DREAM Protein Is Associated with Thyroid Enlargement and Nodular Development

Marcos Rivas, Britt Mellström, Begoña Torres, Gaetano Cali, Alfonso M. Ferrara, Daniela Terracciano, Mariastella Zannini, Gabriella Morreale de Escobar and Jose R. Naranjo

Departamento Biología Molecular y Celular (M.R., B.M., B.T., J.R.N.), Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas (CSIC), 28049 Madrid, Spain; CIBERNED-CNB Centro Investigacion Biomedica en Red de Enfermedades Neurodegerenativas (M.R., B.M., B.T.); Instituto di Endocrinologia ed Oncologia Sperimentale-Consiglio Nazionale delle Ricerche and Dipartimento di Biologia e Patologia Cellulare e Molecolare (G.C., A.M.F., D.T., M.Z.), 80131 Napoli, Italy; and Instituto de Investigaciones Biomédicas, CIBERER-IIB Centro Investigacion Biomedica en Red de Enfermedades Raras (G.M.d.E.), CSIC, 28029 Madrid, Spain

Address all correspondence and requests for reprints to: Jose R. Naranjo, CNB-CSIC, Darwin, 3 28049 Madrid, Spain. E-mail: naranjo{at}cnb.csic.es.

G protein-coupled receptors (GPCRs) are involved in the pathophysiology of a wide range of diseases and constitute an attractive therapeutic target. In the thyroid gland, TSH receptor (TSHR), a member of the GPCR family, is a major regulator of thyroid differentiation and function. Alterations in TSHR activity are often involved in the development of pathologies such as thyroid cancer and thyroid enlargement (goiter). Here we show that DREAM (downstream regulatory element antagonist modulator) modulates TSHR activity through a direct protein-protein interaction that promotes coupling between the receptor and G{alpha}s. In transgenic mice, DREAM overexpression provokes a marked enlargement of the thyroid gland. Increased levels of DREAM protein were observed in human multinodular goiters, suggesting a novel etiopathogenic mechanism in nodular development in humans. Taken together, these findings identify a mechanism for the control of TSHR activity and provide a new approach for the study and treatment of thyroid pathologies associated with impaired TSHR function.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society